Welcome to the joint EGHS-AASLD Live Webcast.

The scientific agenda of this meeting will bring together local and international experts to discuss the COVID-19 pandemic's impact on liver disease and transplantation and review management strategies in COVID-19 that are unique to patients with chronic liver disease and pre & post liver transplantation.
  • Welcome Address and Opening Remarks
  • Overview: Liver Involvement in COVID-19
  • Management of Chronic Liver Diseases During the Pandemic
  • COVID-19 and Liver Transplantation
  • Q&A Session and Closing Remarks
Sameer Al Awadhi
President - Emirates Gastroenterology and Hepatology Society
Dr. Sameer Al Awadhi is Head of Gastroenterology Unit at Rashid Hospital, and leads a top rated physician team of gastroenterology specialists in Dubai, UAE, who help patients find the best treatment options for digestive diseases and liver conditions.

He is also President of the Emirates Gastroenterology and Hepatology Society.
Paul Thuluvath
Program Co-chair
Professor Paul J. Thuluvath, M.D., is the Medical Director of the Institute for Digestive Health & Liver Disease at Mercy, and serves as the Director of the University of Maryland Advanced Hepatology Network, Director for the Center for Liver and Biliary Diseases and the Chief of Gastroenterology at the Mercy Medical Center, Baltimore. He is a Clinical Professor of Medicine at the University of Maryland School of Medicine, Baltimore. Dr. Thuluvath has held various senior leadership positions, including Medical Director of Liver Transplantation, Associate Director of Comprehensive Transplant Progra and the Chief of Hepatology at the Johns Hopkins University School of Medicine before taking up his current position.

Dr. Paul Thuluvath is a known international authority in liver and biliary diseases. Dr Thuluvath is interested in outcome research and has authored more than 270 peer reviewed publications, numerous chapters and 6 text books.
Shiva Kumar
Program Co-chair
Dr Shiva Kumar, MD, FAASLD is Chair of the Department of Gastroenterology & Hepatology and Medical Director of Liver Transplantation in the Digestive Disease Institute, Cleveland Clinic Abu Dhabi, UAE and Clinical Associate Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.
Mark W. Russo
Mark W. Russo, MD, MPH, FAASLD is Medical Director of Liver Transplantation, Chief, Division of Hepatology, and Clinical Professor of Medicine at Carolinas Medical Center-Atrium Health. In the AASLD, Dr. Russo is Chair of the Maintenance of Certification Committee, member of the Nominating Committee, co-director of the 2020 AASLD Transplant Hepatology Board Review course, and member of a working group planning for the future hepatology workforce. He is an Associate Editor for the American Journal of Gastroenterology and serves on the editorial board of Expert Reviews in Gastroenterology and Hepatology and the Journal of Clinical Medicine.
Daniel S. Pratt
Dr. Daniel S. Pratt is an Assistant Professor of Medicine at Harvard Medical School, Clinical Director of Liver Transplantation, and Director of the Autoimmune and Cholestatic Liver Center at the Massachusetts General Hospital. Dr. Pratt was the Medical Director of the Liver Transplant Program and Clinical Chief of the Division of Gastroenterology at the Tufts Medical Center. He joined the faculty of the Harvard Medical School and the MGH Gastrointestinal Unit in 2004. Dr. Pratt's particular area of clinical interest is autoimmune and cholestatic liver disease including autoimmune hepatitis, primary biliary cirrhosis, primary sclerosing cholangitis, and IgG4 associated liver disease. He also does work in cholangiocarcinoma, hepatocellular carcinoma, viral hepatitis, and cirrhosis/endstage liver disease. Dr. Pratt is the head of the PSC Registry at MGH.
Register To Watch Recording
Full name*
Email Address*
Job Title*
Country of Residence*
Marketing Permission
Meeting Minds - FZ LLC will use the information you provide on this form to be in touch with you and to provide updates and marketing. We will not share or sell your personal information. You can unsubscribe anytime by clicking the unsubscribe link in the footer of our emails, or by replying to our emails and asking to be unsubscribed. For more information, please read our privacy policy.
Yes, I consent to receiving emails*
We use BigMarker as our webinar platform. By clicking Register, you acknowledge that the information you provide will be transferred to BigMarker processing in accordance with their Terms of Service and Privacy Policy.